Print page content Print
Increase text size Decrease text size
Text Size




VANGUARD DAMPi is for vaccination of healthy puppies 6–12 weeks of age as an aid in preventing canine distemper caused by canine distemper virus (CDV), infectious canine hepatitis caused by canine adenovirus-1 (CAV-1), respiratory disease caused by CAV-2 and canine parainfluenza caused by CPiV.

The measles virus component helps provide heterotypic immunity against CDV in puppies regardless of circulating CDV antibody levels. Heterotypic immunity should not be relied on for protection after 16 weeks of age.

It contains highly attenuated strains of CDV, human measles virus, canine adenovirus-2 (CAV-2) and canine parainfluenza virus (CPiV).

The CAV-2 component cross-immunizes against CAV-1 and immunizes against CAV-2.

Collapse All
    • The measles virus fraction stimulates active cross-immunity against CDV in puppies as young as 6 weeks of age regardless of levels of maternal antibodies that can interfere with active CDV immunization.
    • CAV-2 cross-immunizes against CAV-1 to help protect dogs against infectious canine hepatitis without producing post-vaccination side effects, including uveitis and corneal opacity, sometimes associated with CAV-1 vaccines.
    • Highly specialized vaccine allows for tailored vaccination protocols in puppies.
  • Directions:

    1. General Directions: Vaccination of healthy dogs 6-12 weeks of age is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL intramuscularly.

    2. Primary Vaccination: Administer a single 1-mL dose to healthy dogs between 6 and 12 weeks of age.

    3. Revaccination: Dogs should be revaccinated at 14-16 weeks of age with a canine distemper, canine adenovirus type 2, and canine parainfluenza vaccine. At the discretion of the veterinarian, annual revaccination with a single dose against any or all of these pathogens is recommended.

Precaution(s): Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze.
Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Inactivate unused contents before disposal.
Caution(s): Vaccination of pregnant bitches should be avoided. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
Warning(s): For use in dogs only. For veterinary use only.




Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.